Thyroid Cancer Clinical Trials in Beijing, Beijing Municipality
9 recruitingBeijing, Beijing Municipality, China
Showing 1–9 of 9 trials
Recruiting
Phase 1Phase 2
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Lung CancerPancreas CancerThyroid Cancer+1 more
Sichuan Enray Pharmaceutical Sciences Company54 enrolled9 locationsNCT07433283
Recruiting
Phase 3
A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma
Thyroid Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.144 enrolled35 locationsNCT06860971
Recruiting
Early Phase 1
A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors
MeningiomaNETsIodine-resistant Thyroid Cancer
Peking Union Medical College Hospital40 enrolled1 locationNCT06632860
Recruiting
Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma
Papillary Thyroid Cancer
Chinese PLA General Hospital3,000 enrolled1 locationNCT06733740
Recruiting
Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer
Recurrent Thyroid Cancer
Chinese PLA General Hospital300 enrolled1 locationNCT06733766
Recruiting
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Breast CancerLiver CancerColorectal, Cancer+10 more
Beijing Friendship Hospital2,700 enrolled4 locationsNCT06363123
Recruiting
Phase 2
Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma
SurgeryThyroid CancerRecurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences140 enrolled1 locationNCT06087068
Recruiting
Phase 3
A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer
Thyroid CancerRecurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1,199 enrolled1 locationNCT06082180
Recruiting
Phase 4
Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma
Medullary Thyroid Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.360 enrolled19 locationsNCT05830500